Antibiotic exposure perturbs the gut microbiota and elevates mortality in honeybees.

Raymann K, Shaffer Z, Moran NA. · 2017

Read Antibiotic exposure perturbs the gut microbiota and elevates mortality in honeybees. by Raymann K, Shaffer Z, Moran NA. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5349420.txt.

Introduction

Kasie Raymann, Zack Shaffer, and Nancy A. Moran studied antibiotic harm in honeybees in PLoS Biology in 2017. Bee keepers dose hives with antibiotics to block larval disease. Gut microbes guard bee health, much as they do in people. Whether the drugs skew that gut mix and leave bees open to attack had not been fully worked out.

Fed a common drug in syrup for days, bees showed lasting shifts in both the size and the make-up of their gut mix. Treated bees died sooner, both back in the hive and in lab tests. When the team added a common germ that preys on weak hosts, the treated bees fell at higher rates. The results tie drug-made gut skew to frailer bees. The authors warn that routine dosing may cost more health than it saves.

Catalog record

CREATORRaymann K, Shaffer Z, Moran NA.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE77 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5349420

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Antibiotic exposure perturbs the gut microbiota and elevates mortality in honeybees By Kasie Raymann, Zack Shaffer, Nancy A Moran, Jeff Gore Published in: PLoS Biology DOI: 10.1371/journal.pbio.2001861 ABSTRACT Abstract Gut microbiomes play crucial roles in animal health, and shifts in the gut microbial community structure can have detrimental impacts on hosts. Studies with vertebrate models and human subjects suggest that antibiotic treatments greatly perturb the native gut community, thereby facilitating proliferation of pathogens. In fact, persistent infections following antibiotic treatment are a major medical issue. In apiculture, antibiotics are frequently used to prevent bacterial infections of larval bees, but the impact of antibiotic-induced dysbiosis (microbial imbalance) on bee health and susceptibility to disease has not been fully elucidated. Here, we evaluated the effects of antibiotic exposure on the size and composition of honeybee gut communities. We monitored the survivorship of bees following antibiotic treatment in order to determine if dysbiosis of the gut microbiome impacts honeybee health, and we performed experiments to determine whether antibiotic exposure increases susceptibility to infection by opportunistic pathogens. Our results show that antibiotic treatment can have persistent effects on both the size and composition of the honeybee gut microbiome. Antibiotic exposure resulted in decreased survivorship, both in the hive and in laboratory experiments in which bees were exposed to opportunistic bacterial pathogens. Together, these results suggest that dysbiosis resulting from antibiotic exposure affects bee health, in part due to increased susceptibility to ubiquitous opportunistic pathogens. Not only do our results highlight the importance of the gut microbiome in honeybee health, but they also provide insights into how antibiotic treatment affects microbial communities and host health. INTRODUCTION Gut microbial communities influence animal health in many ways, including synthesis of vitamins, digestion of food, defense against pathogens, and modulation of behavior, development, and immunity [1]. The gut microbial community can be disturbed by several factors: one of the most potent sources of disturbance for humans and domesticated animals is antibiotic treatment, which can severely alter community size and composition [2]. Treatment with antibiotics has also been associated with the appearance of resistant pathogens such as Clostridium difficile and Salmonella enterica [3–5]. Multiple studies have shown that reduction of gut microbial diversity occurs within a few days of ingestion of antibiotics [1,6,7], and complete recovery of initial bacterial community composition is rarely achieved [7]. In fact, it has been suggested that the overuse of antibiotics has permanently changed our microbiomes, causing an increase in “modern plagues” such as obesity, asthma, diabetes, and certain forms of cancer [8]. However, the duration and extent of antibiotic-induced disturbance in the gut microbiota remains poorly characterized, particularly at the species and strain level where the diversity of the gut community is the greatest [9,10]. Characterizing shifts in size and composition of the microbiota is particularly difficult in mammalian hosts, because of the complexity of their gut communities. Model organisms provide opportunities to study host—microbiome interactions with a level of experimental control that is not achievable in human studies, and models can be used to understand the generality of associations between the microbiome and disease. The gut communities in social insects, such as honeybees (Apis mellifera), are particularly useful as models, because they share common features with mammalian gut communities. As in mammals, honeybees acquire their gut microbiota through social contact [11], in contrast to many invertebrates, which acquire gut bacteria from environmental sources. Similar to humans, the gut microbiota of honeybees is composed of host-specialized bacterial species that live only in the host gut [12] and that show considerable strain diversity within individual hosts [13]. However, in contrast to humans and other mammals, bees have a relatively simple gut microbiota, dominated by only eight core bacterial species, which comprise 95%–99% of bacteria in the gut [14,15]. Therefore, the honeybee provides a tractable system to study the function and evolution of host-associated microbial communities. Additionally, honeybees are important globally as agricultural pollinators [16]. Since 2006, the world's honeybee colonies have undergone elevated mortality, with multiple factors linked to the declines [17,18]. Several results suggest that the gut microbiome contributes to bee health [19–22]. Therefore, dysbiosis (microbial imbalance) may impact honeybee health and susceptibility to disease. Another parallel between the microbiomes of honeybees and humans is the long history of exposure to antibiotics, a potent source of disturbance to gut communities. Antibiotic treatment of bee colonies has been widely used for over 50 y in the United States to prevent a bacterial disease of bee larvae called foulbrood (Paenibacillus larvae) [23–25]. The two antibiotics most commonly used by beekeepers are tetracycline (or the related compound oxytetracycline) and, since 2006, tylosin. Tetracyclines are also used for treating bacterial infections in humans and are commonly incorporated into livestock feed, resulting in the acquisition of tetracycline resistance in many bacteria, including some pathogenic taxa [26]. Likewise, the use of tetracycline in US beekeeping has resulted in an accumulation of resistance genes in microbiomes of US honeybees as compared to bumblebees or honeybees in countries that do not use antibiotics in beekeeping [27]. Widespread antibiotic resistance has been reported in P. larvae, the bacterial pathogen that causes American Foulbrood (AFB) [28], and a resistance gene (tetL) found in P. larvae is identical in sequence to one of the resistance loci harbored by honeybee gut symbionts [27], suggesting past horizontal transfer between commensal gut bacteria and this pathogen. In this study, we evaluate the effects of tetracycline exposure on bee survivorship and on the size and composition of honeybee gut communities. We sampled treated bees at different time-points postexposure to determine if the microbiome recovers to pretreatment status. We monitored post-treatment survival within hives to determine if gut dysbiosis impacts honeybee health, and we tested whether antibiotic exposure increases susceptibility to infection by opportunistic pathogens present in hives. Our results show that treatment with tetracycline severely alters both the size and composition of the honeybee gut microbiome. Moreover, the perturbations caused by tetracycline treatment were still evident one week after bees were returned to their hives following exposure. Our results show that tetracycline-induced dysbiosis can decrease the survival rate of bees and suggest that this reflects increased susceptibility to opportunistic pathogens. RESULTS Adult worker bees were collected from a brood frame from a single hive. Bees were fed filter-sterilized sucrose syrup (controls) or tetracycline suspended in filter-sterilized sucrose syrup (treatments) for 5 d before being returned to the hive or maintained in the laboratory under sterile (i.e., kept only with other tetracycline-treated bees from their cohort) or exposed (i.e., with normal workers collected from their hive) recovery conditions. In order to determine how antibiotic treatment affects longevity and the size and composition of the gut microbiome, bees were censused and sampled at several time points post-treatment. The gut microbiota was assessed for total number of bacteria and for community composition using quantitative PCR and deep amplicon sequencing of a region of the bacterial 16S rRNA gene. Antibiotic treatment resulted in major changes in community size starting on the first sampling day (Day 0, before reintroduction to the hive) (Fig 1A and 1B). None of the core species was completely eradicated by tetracycline treatment, but the total bacterial abundance as well as the absolute abundance of several species decreased in

Read the complete text